240 related articles for article (PubMed ID: 23650079)
1. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
[TBL] [Abstract][Full Text] [Related]
2. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
Rice MS; Hankinson SE; Tworoger SS
Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
[TBL] [Abstract][Full Text] [Related]
3. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
4. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.
Lessard-Anderson CR; Handlogten KS; Molitor RJ; Dowdy SC; Cliby WA; Weaver AL; Sauver JS; Bakkum-Gamez JN
Gynecol Oncol; 2014 Dec; 135(3):423-7. PubMed ID: 25316178
[TBL] [Abstract][Full Text] [Related]
5. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
[TBL] [Abstract][Full Text] [Related]
6. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
[TBL] [Abstract][Full Text] [Related]
7. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.
Hankinson SE; Hunter DJ; Colditz GA; Willett WC; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
JAMA; 1993 Dec; 270(23):2813-8. PubMed ID: 8133619
[TBL] [Abstract][Full Text] [Related]
8. The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.
Wang C; Liang Z; Liu X; Zhang Q; Li S
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27854255
[TBL] [Abstract][Full Text] [Related]
9. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
10. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
11. Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis.
Rice MS; Murphy MA; Tworoger SS
J Ovarian Res; 2012 May; 5(1):13. PubMed ID: 22587442
[TBL] [Abstract][Full Text] [Related]
12. Tubal ligation and ovarian cancer risk in African American women.
McNamara C; Abbott SE; Bandera EV; Qin B; Peres LC; Camacho F; Moorman PG; Alberg AJ; Barnholtz-Sloan JS; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Schildkraut JM; Terry P
Cancer Causes Control; 2017 Oct; 28(10):1033-1041. PubMed ID: 28871344
[TBL] [Abstract][Full Text] [Related]
13. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
14. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
[TBL] [Abstract][Full Text] [Related]
15. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
[TBL] [Abstract][Full Text] [Related]
16. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer.
Irwin KL; Weiss NS; Lee NC; Peterson HB
Am J Epidemiol; 1991 Aug; 134(4):362-9. PubMed ID: 1877597
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
18. Hysterectomy With and Without Oophorectomy, Tubal Ligation, and Risk of Cardiovascular Disease in the Nurses' Health Study II.
Farland LV; Rice MS; Degnan WJ; Rexrode KM; Manson JE; Rimm EB; Rich-Edwards J; Stewart EA; Cohen Rassier SL; Robinson WR; Missmer SA
J Womens Health (Larchmt); 2023 Jul; 32(7):747-756. PubMed ID: 37155739
[No Abstract] [Full Text] [Related]
19. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
20. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.
Stewart LM; Holman CD; Aboagye-Sarfo P; Finn JC; Preen DB; Hart R
Gynecol Oncol; 2013 Feb; 128(2):260-4. PubMed ID: 23116937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
